393 Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis without topical corticosteroids: an updated network meta-analysis.

MLA

Silverberg, Jonathan I., et al. “393 Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-Analysis.” British Journal of Dermatology, vol. 188, June 2023, pp. 1–2. EBSCOhost, https://doi.org/10.1093/bjd/ljad162.018.

APA

Silverberg, J. I., Hong, H. C., Thyssen, J. P., Calimlim, B. M., Lee, W.-J., Teixeira, H. D., Collins, E. B., Crowell, M. M., Johnson, S. J., & Armstrong, A. W. (2023). 393 Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis without topical corticosteroids: an updated network meta-analysis. British Journal of Dermatology, 188, 1–2. https://doi.org/10.1093/bjd/ljad162.018

Chicago

Silverberg, Jonathan I, H Chih-ho Hong, Jacob P Thyssen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Eric B Collins, Marjorie M Crowell, Scott J Johnson, and April W Armstrong. 2023. “393 Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-Analysis.” British Journal of Dermatology 188 (June): 1–2. doi:10.1093/bjd/ljad162.018.